what you should have been told

Referenced - COVID-19 Vaccines, What You Should Have Been Told - 17 September 2022

1. Winters N. WATCH: Explosive, Unearthed Video Shows Peter Daszak Describing ‘Chinese Colleagues’ Developing ‘Killer’ Coronaviruses. The National Pulse. June 8, 2021. Accessed September 17, 2022. https://thenationalpulse.com/2021/06/08/daszak-reveals-chinese-colleagues-manipulating-coronaviruses

2. Song L, Gao J, Wu Z. Laboratory-acquired infections with Brucella bacteria in China. Biosafety and Health. 2021;3(2):101-104. doi:10.1016/j.bsheal.2020.07.010

3. Walgate R. SARS escaped Beijing lab twice. Genome Biol. 2004;4:spotlight-20040427-03. doi:10.1186/gb-spotlight-20040427-03

4. House Foreign Affairs Committee Minority Staff Report. The Origins of the COVID-19 Global Pandemic, Including the Roles of the Chinese Communist Party and the World Health Organization. Updated September 21, 2020. Accessed September 17, 2022. https://gop-foreignaffairs.house.gov/wp-content/uploads/2020/09/Final-Minority-Report-on-the-Origins-of-the-COVID-19-Global-Pandemic-Including-the-Roles-of-the-CCP-and-WHO-9.20.20-Coverpage.pdf

5. Fleming RM. Is COVID-19 a Bioweapon? A Scientific and Forensic Investigation. Skyhorse Publishing; 2021:86.

6. Boswell J, Gould M. The Pentagon gave $39 MILLION to Dr. Peter Daszak’s EcoHealth Alliance - the charity that funded coronavirus research at the Wuhan lab accused of being the source of the outbreak, federal data reveals. Mail Online. June 4, 2021. Accessed September 17, 2022. https://www.dailymail.co.uk/news/article-9652287/The-Pentagon-funneled-39million-charity-funded-Wuhan-lab.html

7. Cohen J. Prophet in Purgatory: EcoHealth Alliance’s Peter Daszak is fighting accusations that his pandemic prevention work helped spark COVID-19. Science. November 17, 2021. Accessed September 17, 2022. https://www.science.org/content/article/we-ve-done-nothing-wrong-ecohealth-leader-fights-charges-his-research-helped-spark-covid-19

8. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-273. doi:10.1038/s41586-020-2012-7

9. EcoHealth Alliance. Project DEFUSE: Defusing the Threat of Bat-borne Coronaviruses, Proposal: Volume 1. 27 March, 2021. Accessed September 17, 2022. https://drasticresearch.files.wordpress.com/2021/09/main-document-preempt-volume-1-no-ess-hr00118s0017-ecohealth-alliance.pdf

10. U.S. Department of State. Biological Weapons Convention. Accessed September 17, 2022. https://www.state.gov/biological-weapons-convention/

11. National Center for Biotechnology Information. PubChem Patent Summary for US-9884895-B2. Updated 6 February, 2018. Accessed September 17, 2022. https://pubchem.ncbi.nlm.nih.gov/patent/US-9884895-B2

12. The White House Office of Science and Technology Policy and Department of Health and Human Services. Doing Diligence to Assess the Risks and Benefits of Life Sciences Gain-of-Function Research. October 17, 2014. Accessed September 17, 2022. https://obamawhitehouse.archives.gov/blog/2014/10/17/doing-diligence-assess-risks-and-benefits-life-sciences-gain-function-research

13. U.S. Department of Health and Human Services. U.S. Government Gain-of-Function Deliberative Process and Research Funding Pause on Selected Gain-of-Function Research Involving Influenza, MERS, and SARS Viruses. October 17, 2014. Accessed September 17, 2022. http://www.phe.gov/s3/dualuse/Documents/gain-of-function.pdf

14. Menachery VD, Yount Jr BL, Debbink K, et al. A SARS-Like Cluster of Circulating Bat Coronaviruses Shows Potential for Human Emergence. Nat. Med. 2015;21(12):1508-1513. doi:10.1038/nm.3985

15. Yang Y, Liu, C, Du L, et al. Two Mutations Were Critical for Bat-to-Human Transmission of Middle East Respiratory Syndrome Coronavirus. J Virol. 2015;89(17):9119-9123. doi:10.1128/JVI.01279-15

16. Ambati BK, Varshney A, Lundstrom K, et al. MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site. Front. Virol. 2022;2. doi:10.3389/fviro.2022.834808

17. National Institutes of Health. Notice Announcing the Removal of the Funding Pause for Gain-of-Function Research Projects. December 19, 2017. Accessed September 17, 2022. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-071.html

18. U.S. Department of Health and Human Services. Department of Health and Human Services Framework for Guiding Funding Decisions about Proposed Research Involving Enhanced Potential Pandemic Pathogens. 2017. Accessed September 17, 2022. https://www.phe.gov/s3/dualuse/Documents/P3CO.pdf

19. Calisher C, Carroll D, Colwell R, et al. Correspondence: Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19. Lancet. 2020;395(10226):E42-E43. doi:10.1016/S0140-6736(20)30418-9

20. World Health Organisation. WHO-convened Global Study of Origins of SARS-CoV-2: China Part, Joint WHO-China Study: 14 January-10 February 2021, Joint Report. Updated April 2, 2021. Accessed September 17, 2022. https://www.who.int/docs/default-source/coronaviruse/final-joint-report_origins-studies-6-april-201.pdf

21. World Health Organization. WHO calls for further studies, data on origin of SARS-CoV-2 virus, reiterates that all hypotheses remain open. March 30, 2021. Accessed September 17, 2022. https://www.who.int/news/item/30-03-2021-who-calls-for-further-studies-data-on-origin-of-sars-cov-2-virus-reiterates-that-all-hypotheses-remain-open

22. Task Forces. The Lancet COVID-19 Commission. Accessed September 17, 2022. https://covid19commission.org/task-forces

23. McKay B. Covid-19 Panel of Scientists Investigating Origins of Virus Is Disbanded. Wall Street Journal. September 25, 2021. Accessed September 17, 2022. https://www.wsj.com/articles/covid-19-panel-of-scientists-investigating-origins-of-virus-is-disbanded-11632571202

24. Scientific Advisory Group for the Origins of Novel Pathogens (SAGO). Preliminary Report of the SAGO. June 9, 2021. Accessed September 17, 2022. https://cdn.who.int/media/docs/default-source/scientific-advisory-group-on-the-origins-of-novel-pathogens/sago-report-09062022.pdf

25. Sachs JD, Karim SSA, Aknin L, et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet. Published online September 14, 2021. doi:10.1016/S0140-6736(22)01585-9

26. Fleming RM. Is COVID-19 a Bioweapon? A Scientific and Forensic Investigation. Skyhorse Publishing; 2021.

27. TED. How mRNA Medicine Will Change the World | Melissa J. Moore | TED. Posted May 18, 2022. Accessed September 17, 2022. https://www.youtube.com/watch?v=h5D3mv8ewCY

28. Clark AC. Protein folding: are we there yet?. Arch Biochem Biophys. 2008;469(1):1-3. doi:10.1016/j.abb.2007.10.007

29. Soto C, Satani N. The intricate mechanisms of neurodegeneration in prion diseases. Trends Mol Med. 2011;17(1):14-24. doi:10.1016/j.molmed.2010.09.001

30. Mauro, VP. Codon Optimization in the Production of Recombinant Biotherapeutics: Potential Risks and Considerations. BioDrugs. 2018; 32:69-81. doi:10.1007/s40259-018-0261-x

31. McKernan K, Kyriakopoulos, A, McCullough, P. Differences in Vaccine and SARS-CoV-2 Replication Derived mRNA: Implications for Cell Biology and Future Disease. OSF Preprints. Updated online September 14, 2021. doi:10.31219/osf.io/bcsa6

32. ProImmune thinkpeptides. Katerina Alexaki: Effects of codon optimization on biotherapeutics: Implications for immunogenicity. Posted September 27, 2019. Accessed September 17, 2022. https://www.youtube.com/watch?v=aZwYEpumQRU

33. Proteintech. How does blood coagulate? Accessed September 17, 2022. https://www.ptglab.com/news/blog/how-does-blood-coagulate

34. Santacroce R., Acquila M, Belvini D. et al. Identification of 217 unreported mutations in the F8 gene in a group of 1,410 unselected Italian patients with hemophilia A. J Hum Genet. 2008;53:275-284. doi:10.1007/s10038-007-0238-y

35. Philip J, Sarkar RS, Kumar S, Prathip BR, Pathak A. Factor IX deficiency (Christmas disease). Med J Armed Forces India. 2012;68(4):379-380. doi:10.1016/j.mjafi.2011.12.007

36. Alexaki A, Hettiarachchi GK, Athey JC, et al. Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies. Sci Rep. 2019;9(1):15449. Published online October 29, 2019. doi:10.1038/s41598-019-51984-2

37. Endoh T, Kawasaki Y, Sugimoto N. Suppression of gene expression by G-quadruplexes in open reading frames depends on G-quadruplex stability. Angew Chem Int Ed Engl. 2013;52(21):5522-5526. doi:10.1002/anie.201300058

38. Yu CH, Teulade-Fichou MP, Olsthoorn RC. Stimulation of ribosomal frameshifting by RNA G-quadruplex structures. Nucleic Acids Res. 2014;42(3):1887-1892. doi:10.1093/nar/gkt1022

39. Olsthoorn RC. G-quadruplexes within prion mRNA: the missing link in prion disease?. Nucleic Acids Res. 2014;42(14):9327-9333. doi:10.1093/nar/gku559

40. Sen D, Gilbert W. Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis. Nature. 1988;334(6180):364-366. doi:10.1038/334364a0

41. National Human Genome Research Institute. Frameshift Mutation. Updated September 23, 2021. Accessed September 17, 2022. https://www.genome.gov/genetics-glossary/Frameshift-Mutation

42. Rambaran RN, Serpell LC. Amyloid fibrils: abnormal protein assembly. Prion. 2008;2(3):112-117. doi:10.4161/pri.2.3.7488

43. Baker KR, Rice L. The amyloidoses: clinical features, diagnosis and treatment. Methodist Debakey Cardiovasc J. 2012;8(3):3-7. doi:10.14797/mdcj-8-3-3

44. Viola KL, Klein WL. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis. Acta Neuropathol. 2015;129(2):183-206. doi:10.1007/s00401-015-1386-3

45. Nyström S, Hammarström P. Amyloidogenesis of SARS-CoV-2 Spike Protein. J. Am. Chem. Soc. 2022;144 (20):8945-8950. doi:10.1021/jacs.2c03925

46. Trigoso E. Embalmers Have Been Finding Numerous Long, Fibrous Clots That Lack Post-Mortem Characteristics. The Epoch Times. Updated September 7, 2022. Accessed September 17, 2022. https://www.theepochtimes.com/mkt_app/embalmers-have-been-finding-numerous-long-fibrous-clots-that-lack-post-mortem-characteristics_4696015.html

47. Leifler KS. Linköping University. Possible discovery of mechanism behind mysterious COVID-19 symptoms. May 19, 2022. Accessed September 17, 2022. https://liu.se/en/news-item/mojlig-mekanism-bakom-gatfulla-symtom-vid-covid-19-upptackt

48. Aldén M, Falla FO, Yang D, et al. Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. Curr. Issues Mol. Biol. 2022; 44(3):1115-1126. doi:10.3390/cimb44030073

49. Domazet-Lošo T. mRNA Vaccines: Why Is the Biology of Retroposition Ignored?. Genes (Basel). 2022;13(5):719. Published 2022 Apr 20. doi:10.3390/genes13050719

50. U.S Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee – 10/26/2021. Posted October 26, 2021. Accessed September 17, 2022. https://www.youtube.com/watch?v=laaL0_xKmmA

51. Mansanguan S, Charunwatthana P, Piyaphanee W, Dechkhajorn W, Poolcharoen A, Mansanguan C. Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents. Trop Med Infect Dis. 2022;7(8):196. Published online August 19, 2022. doi:10.3390/tropicalmed7080196

52. Canakci ME, Sevik OE, Dereli G, Mert KU, Acar N. Vaccine-Induced Myocarditis in Two Intern Doctors in the Same Night Shift. Prehosp Disaster Med. 2022;37(5):698-700. doi:10.1017/S1049023X22001078

53. Gill JR, Tashjian R, Duncanson E. Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose. Arch Pathol Lab Med. 2022;146(8):925-929. doi:10.5858/arpa.2021-0435-SA

54. Oster ME, Shay DK, Su JR, et al. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. JAMA. 2022;327(4):331–340. doi:10.1001/jama.2021.24110

55. Debionne P. Impffolgen: Krankenkasse BKK schreibt Brief an Paul-Ehrlich-Institut. Updated February 25, 2022. Accessed September 17, 2022. https://www.berliner-zeitung.de/news/impffolgen-krankenkasse-bkk-schreibt-brief-an-paul-ehrlich-institut-li.213676

56. OpenVAERS. COVID Data. Accessed September 17, 2022. https://openvaers.com/covid-data

57. Office for National Statistics. Weekly provisional figures on death registrations in England and Wales, registered 2021 and 2022 and five-year averages. Posted September 13, 2021. Accessed September 17, 2022. https://www.ons.gov.uk/file?uri=/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/datasets/weeklyprovisionalfiguresondeathsregisteredinenglandandwales/2021/publishedweek522021.xlsx

58. World Economic Forum. How to Survive the 21st Century | DAVOS 2020. Posted January 23, 2020. Accessed September 17, 2022. https://www.youtube.com/watch?v=eOsKFOrW5h8

59. World Health Organization. Global COVID-19 Vaccination Strategy in a Changing World: July 2022 update. Posted July 22, 2022. Accessed September 17, 2022. https://www.who.int/publications/m/item/global-covid-19-vaccination-strategy-in-a-changing-world--july-2022-update

60. Jawa V, Joubert MK, Zhang Q, et al. Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics. AAPS J. 2016;18(6):1439-1452. doi:10.1208/s12248-016-9948-4

61. Krutzke L, Rösler R, Allmendinger E, et al. Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine. eLife. 2022;11:e78513. doi:10.7554/eLife.78513

62. Committee for Medicinal Product for Human Use (CHMP), European Medicines Agency. Assessment report Comirnaty. Updated February 19, 2021. Accessed September 17, 2022. https://www.ema.europa.eu/en/documents/assessment-report/comirnaty-epar-public-assessment-report_en.pdf

63. Advance Purchase Agreement: European Commission and Pfizer-BioNTech. Published April 17, 2021. Accessed June, 11, 2022. https://www.rai.it/dl/doc/2021/04/17/1618676600910_APA%20BioNTech%20Pfizer__.pdf

64. Weissman J. Trade Secret. Accessed September 17, 2022. https://www.alltherisks.com/trade-secret

65. Yu N, Zhang X, Gao Y, You H, Zhang J, Miao P. Highly Sensitive Endotoxin Assay Combining Peptide/Graphene Oxide and DNA-Modified Gold Nanoparticles. ACS Omega. 2019;4(10):14312-14316. Published online August 22, 2019. doi:10.1021/acsomega.9b02013

66. Children of God For Life. Abortion-Tainted Vaccines for US and Canada and Ethical Alternatives. Accessed September 17, 2022. https://cogforlife.org/wp-content/uploads/Abortion-Tainted-Vaccines.pdf

67. Akhtar A. The flaws and human harms of animal experimentation. Camb Q Healthc Ethics. 2015;24(4):407-419. doi:10.1017/S0963180115000079

68. Office for Health Improvement & Disparities. Abortion statistics, England and Wales: 2021. Updated August 25, 2022. Accessed September 17, 2022. https://www.gov.uk/government/statistics/abortion-statistics-for-england-and-wales-2021/abortion-statistics-england-and-wales-2021

69. Kessler R. Disease X: The Next Pandemic. EcoHealth Alliance. Accessed September 17, 2022. https://www.ecohealthalliance.org/2018/03/disease-x

70. World Health Organization. Implementing the Immunization Agenda 2030. January 7, 2021. Accessed September 17, 2022. https://www.who.int/publications/m/item/implementing-the-immunization-agenda-2030

71. Ministry of Defence, in partnership with Bundeswehr Office for Defence Planning. Human Augmentation – The Dawn of a New Paradigm A strategic implications project. May 2021. Accessed September 17, 2022. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/986301/Human_Augmentation_SIP_access2.pdf